Targeted Therapy with Larotrectinib in NTRK Fusion Cancers: Results from the NCI-MATCH ECOG-ACRIN Trial
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 27, 2026. n Precision oncology has transformed cancer
Topic
Cancer Medicine
22 articles on Cancer Medicine, written for patients and carers arranging specialty treatment.
-
-
FDA Gives Full Approval to Encorafenib Combo for BRAF V600E Metastatic Colorectal Cancer
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 26, 2026. n The US FDA has granted
-
New First-Line Option: FDA Approves Acalabrutinib Combo for CLL/SLL
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 24, 2026. n A new frontline treatment option
-
Fixed-Duration Venetoclax vs Continuous Ibrutinib in Untreated CLL: What the CLL17 Trial Means for Patients
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 21, 2026. n Chronic lymphocytic leukemia (CLL) is
-
Does Ribociclib Still Help After 3 Years? The NATALEE Trial’s 4-Year Follow-Up Answers
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 21, 2026. n For patients with hormone receptor–positive,
-
New CDK4/6 Strategies in HR+/HER2– Breast Cancer: Imlunestrant ± Abemaciclib and the Avutometinib Triplet
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 20, 2026. n Hormone receptor–positive, HER2-negative (HR+/HER2–) metastatic
-
CDK4/6 Inhibitors in Prostate Cancer: What CYCLONE 2 Tells Us About Abemaciclib + Abiraterone
Metastatic castration-resistant prostate cancer (mCRPC) remains one of the most challenging stages of prostate cancer to treat. Although several therapies
-
What Are Hematologic Malignancies? Types, Causes, and Global Burden
Understanding blood cancers and their impact on global health Hematologic malignancies, commonly known as blood cancers, represent a diverse group
-
Skin Cancer: Types, Symptoms, Diagnosis, and Treatment Options
A comprehensive guide to understanding, detecting, and treating skin cancer Skin cancer is the most common form of cancer worldwide,
-
FDA Approves Breakthrough Liquid Biopsy Test for Advanced Colorectal Cancer Treatment
New diagnostic tool offers hope for personalized treatment of BRAF V600E-mutant metastatic colorectal cancer In a significant advancement for cancer
Still have a question?
We reply to every enquiry within one working day.